ArticleGeneral thoracic and cardiovascular surgery2026
Feasibility and surgical outcomes of thoracoscopic surgery for spontaneous pneumothorax with scope manipulation performed by clinical engineers: a retrospective comparative study.
Article in General thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the feasibility and surgical outcomes of thoracoscopic surgery for spontaneous pneumothorax (SP) with scope manipulation performed by clinical engineers (CEs) as the initial implementation of task shifting in thoracoscopic surgery at our institution.
methodsWe retrospectively analyzed patients with SP who underwent thoracoscopic surgery between April 2023 and March 2026. Baseline characteristics and surgical outcomes were compared between procedures with scope manipulation performed by CEs and those with scope manipulation performed by surgeons.
resultsThe CE group included 38 patients and the Surgeon group included 37 patients, with no statistically significant differences in baseline patient characteristics. There were also no statistically significant differences in operative time, blood loss, postoperative drainage duration, postoperative hospital stay, complication rate, and recurrence-free survival between the groups (operative time: 60.0 ± 22.9 vs. 56.4 ± 25.1 min, P = 0.52; blood loss: 10 [10-10] vs. 10 [10-10] mL, P = 0.15; postoperative drainage duration: 1.4 ± 1.1 vs. 1.2 ± 0.4 days, P = 0.19; postoperative hospital stay: 4.6 ± 5.2 vs. 2.9 ± 2.6 days, P = 0.09; complication rate: 13.2% vs. 5.4%, P = 0.43; recurrence-free survival: log-rank P = 0.24).
conclusionsThoracoscopic surgery for SP appears feasible when scope manipulation is performed by CEs, with no statistically significant differences in the evaluated surgical outcomes between the CE and Surgeon groups.
Indexed as
Identifiers
42635703What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.